 | Up a level |
Raptis, Catherine E; Berger, Christoph T; Ciurea, Adrian; Andrey, Diego O; Polysopoulos, Christos; Lescuyer, Pierre; Maletic, Tanja; Riek, Myriam; Scherer, Almut; von Loga, Isabell; Safford, Judith; Lauper, Kim; Möller, Burkhard; Vuilleumier, Nicolas; Finckh, Axel; Rubbert-Roth, Andrea (2022). Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases. Frontiers in immunology, 13(1016927), p. 1016927. Frontiers Research Foundation 10.3389/fimmu.2022.1016927
Ciurea, Adrian; Papagiannoulis, Eleftherios; Bürki, Kristina; von Loga, Isabell; Micheroli, Raphael; Möller, Burkhard; Rubbert-Roth, Andrea; Andor, Michael; Bräm, René; Müller, Angela; Dan, Diana; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Finckh, Axel (2021). Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort. Annals of the rheumatic diseases, 80(2), pp. 238-241. BMJ Publishing Group 10.1136/annrheumdis-2020-218705
